Outcome of bortezomib plus chemotherapy with or without stem cell transplantation for treatment of multiple myeloma

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 29, Issue 6, 2008, Pages 397-400

  Wang, Ya fei ^a   Deng, Shu hui ^a   Wu, Tong ^a   Xu, Yan ^a   Zou, De hui ^a   Wang, Ying ^a   Zhao, Yao zhong ^a   Qiu, Lu gui ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; PYRAZINE DERIVATIVE; THALIDOMIDE;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77950488331     PISSN: 02532727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)